Tonight, ask yourself: has your doctor tested your ferritin and transferrin saturation — not just a standard blood count? If the answer is no, that's the only step that matters before buying any iron supplement. And if you take thyroid medication, your iron must go at least 4 hours after your thyroid tablet — starting tonight.
Iron is the conductor inside every power system your body runs — not just in red blood cells carrying oxygen, but inside the tiny generators in each muscle cell. When iron is low, it's not just the delivery trucks that slow down; the factory itself loses power. This is why you can test "fine" for anaemia (the oxygen delivery trucks look okay) but still feel profoundly exhausted (the energy factory inside your cells is starved).
That's the general answer. Your stack is different.
Check your whole stackOral supplementation — deficiency testing, forms comparison, and the drug interaction your pharmacist probably never mentioned
Tonight, ask yourself: has your doctor tested your ferritin and transferrin saturation — not just a standard blood count? If no, that's your only priority before buying any iron supplement.
A standard blood test (CBC) only checks oxygen-carrying red blood cells. Ferritin measures your iron stores — and you can have profound fatigue from depleted stores with a completely normal CBC. Millions of people are told their blood work is fine when the test that matters was never ordered.
— And if you take thyroid medication: your iron must go at least 4 hours after your thyroid tablet, starting tonight.
The Verdict
Millions of exhausted people have "normal" blood tests — because their doctor tested the wrong thing.
Iron is the conductor inside every power system your body runs — not just in the red blood cells carrying oxygen, but inside the tiny generators in each muscle cell. When iron runs low, it's not just the delivery trucks that slow down; the factory itself loses power. This is why you can test completely "fine" for anaemia (the oxygen delivery trucks look okay) but still feel profoundly exhausted (the energy generators inside your cells are starved).
Want the full evidence? Keep scrolling
What People Claim
Iron supplements have become a cultural shorthand for tiredness — particularly among premenopausal women. The messaging is everywhere:
"Iron is your energy mineral. Low iron = low energy. Every active woman needs supplemental iron. Ferrous sulfate is the cheap generic — serious athletes upgrade to chelated or liposomal forms for 3-5x better results."
Athletic supplement brands claim iron raises VO2max and speeds recovery. Women's wellness brands claim any ferritin under 50 µg/L causes fatigue and should be treated. Plant-based nutrition brands position iron supplements as non-negotiable for vegans and vegetarians.
Each of these camps has a partial truth underneath significant overreach. The challenge is that the gap between "iron helps depleted people" and "everyone low-ish on iron needs to supplement" is where most of the marketing harm happens.
What the Evidence Shows
| Claimed Benefit | Strength | Key Study | Verdict |
|---|---|---|---|
|
IDA correction — raising haemoglobin (red blood cell protein)
STRONG
What would change this: a large RCT showing haemoglobin response below +1.5 g/dL after 3-4 weeks on adequate dosing in confirmed iron-deficiency anaemia — currently no such evidence exists. |
Very strong +2 g/dL Hb within 3-4 weeks |
Kamath 2023 SRMA N=1,014 |
WORKS |
|
Non-anemic fatigue (depleted iron stores without anaemia)
STRONG
What would change this: a well-powered RCT showing no fatigue improvement in people with ferritin under 30 µg/L and normal haemoglobin — the Harrabi 2025 finding would need direct contradiction at larger N. |
Strong Fatigue ↓ (p<0.001); muscle endurance ↑ |
Harrabi 2025 PLoS One N=23 |
WORKS |
|
Athletic submaximal endurance (depleted athletes)
MODERATE
What would change this: larger RCTs in well-matched athlete populations with strict iron depletion criteria. N=23 is an early signal, not definitive. |
Moderate Muscle endurance ↑, fatigue ↓ |
Harrabi 2025 | CONDITIONAL |
|
VO2max / peak strength improvement
WEAK
What would change this: a multi-centre RCT in athletes with confirmed NAID (ferritin 10-20 µg/L, normal Hb) showing VO2max improvement — current data does not cross the statistical threshold (p=0.008 vs corrected threshold 0.00625). |
Weak NS after strict statistical correction |
Harrabi 2025 | LIMITED |
|
CKD (kidney disease) with iron deficiency + high phosphate
STRONG
What would change this: failure in a real-world Phase IV study — Phase III evidence is robust at N=141-190. |
Strong Hb ↑ 0.62 g/dL vs placebo (p<0.0001) |
Pergola/Wang 2021/2023 Phase III N=141-190 |
WORKS (CKD-specific) |
|
Healthy adult deficiency prevention
MODERATE
What would change this: evidence of harm from supplementing at RDA levels in replete individuals — current RDA evidence is robust but prevention trials in already-replete adults are limited. |
Moderate RDA established; deficiency prevention robust |
NIH ODS; EFSA | WORKS (if deficient) |
The standard blood test (CBC) measures haemoglobin — the oxygen-carrying protein in red blood cells. But iron does far more than oxygen transport. When iron stores drop below a critical threshold (ferritin under 30 µg/L), the mitochondrial energy generators in muscle cells are starved before haemoglobin is affected. The result: profound fatigue, cognitive fog, and reduced exercise capacity with "normal" blood work. Millions of people — predominantly premenopausal women — are told their results are fine when the decisive marker was never ordered.
Ferritin is an "acute phase reactant" — it rises with inflammation independent of iron stores. A ferritin of 60 µg/L in a patient with high inflammation (CRP above 5 mg/L) can represent true iron deficiency. The standard cutoff of under 15 µg/L misses this completely. When inflammation is present, transferrin saturation below 20% is the reliable secondary marker that cuts through the noise.
How It Works
Iron is a transition metal required for virtually every energy-producing process in human biology. Here's what it's actually doing inside your body:
Iron is the central atom in haemoglobin (the oxygen-carrying protein in red blood cells) and myoglobin (in muscle tissue). Without sufficient iron, oxygen delivery drops, and every aerobic process degrades. This is classical anaemia — the condition most doctors test for.
Iron is embedded in the electron transport chain — the mitochondrial machinery that produces ATP (your cellular fuel) — as iron-sulfur clusters in cytochromes I-III. When iron is scarce, ATP production falls. This is why people with depleted iron stores (even normal haemoglobin) feel profoundly exhausted: the power generators themselves are running on reduced capacity, not just the oxygen delivery.
Iron is a cofactor for the enzymes that produce dopamine (tyrosine hydroxylase) and serotonin (tryptophan hydroxylase). Iron deficiency disrupts mood regulation and cognition independent of energy production. This explains why people often report brain fog and mood disruption alongside physical fatigue.
Your body controls iron absorption through hepcidin — a liver protein that acts as the master gatekeeper. When iron stores are adequate, or when inflammation is present, hepcidin rises, binds to the iron export protein (ferroportin), and causes it to break down. This traps iron inside gut cells where it's lost when those cells shed.
Large single doses of iron (60 mg or more) trigger a hepcidin spike that blocks absorption for 24-48 hours. This is exactly why alternate-day dosing outperforms daily dosing for fractional absorption (21.8% vs 16.3% absorbed per dose). Advanced forms — ferrous bisglycinate and liposomal iron — partially or completely bypass this system through different absorption pathways.
The Debate
Kamath 2023 SRMA (N=1,014)
Alternate-day dosing achieves 21.8% fractional absorption vs 16.3% for daily dosing (p=0.0013). The hepcidin mechanism predicts this: each dose triggers suppression that lingers 24-48 hours. Every-other-day dosing allows recovery.
Patel 2024 (N=71,677 US veterans)
Multiple daily doses achieved faster haemoglobin rise in real-world IDA correction despite lower fractional efficiency. The larger total daily payload compensates when urgent correction is the goal.
Direction: Both camps are right about different endpoints. Alternate-day wins on absorption efficiency — use it for NAID and maintenance. Daily or multiple doses win on speed of clinical correction — use it when urgent anaemia correction is the goal.
Modern view (Harrabi 2025; Gupta Banerjee 2026)
Depleted iron stores (ferritin below 30 µg/L) with normal haemoglobin causes real, measurable fatigue via mitochondrial iron-sulfur depletion. Treat it. The cells are starved even if the delivery trucks look fine.
Traditional clinical paradigm
Withhold iron supplementation until haemoglobin drops to confirm clinical anaemia. Concern: excess iron is pro-oxidant and supplementing without true deficiency confirmation risks overload.
Direction: The modern view is better supported. Treat depleted stores when ferritin is below 30 µg/L and symptoms match — but always confirm transferrin saturation to rule out false-low ferritin in inflamed populations.
Gupta Banerjee 2026 SR
Liposomal iron and ferrous bisglycinate bypass hepcidin through M-cell endocytosis and chelation stability. In IBD and mild-moderate CKD, haemoglobin response approaches that of IV iron in newer trials.
Traditional gastroenterology / nephrology
IV iron remains vastly superior in severe inflammatory states where mucosal hepcidin block is complete. Oral iron of any form fails when the gut absorption pathway is severely compromised.
Direction: Advanced oral forms (not ferrous sulfate) are a reasonable first-line attempt in mild-moderate inflammatory states. Severe IBD flares and dialysis-dependent CKD still warrant IV iron.
Honest Limitations
The Protocol
All doses below refer to elemental iron — the active fraction. A "325 mg ferrous sulfate" tablet contains only 65 mg elemental iron. Always check the label for elemental iron content, not total tablet weight.
| Population | Dose (elemental) | Timing | Best Form |
|---|---|---|---|
| Healthy men / postmenopausal women (maintenance) | 8 mg/day | With food | Any standard form |
| Premenopausal women (daily requirement) | 18 mg/day | With vitamin C, away from tea and coffee | Ferrous bisglycinate |
| Vegetarians / vegans | 14 mg (men), 32 mg (women)/day | Away from grains and legumes | Ferrous bisglycinate |
| Adults with confirmed iron-deficiency anaemia | 60–100 mg/day, 3–6 months | Morning, empty stomach OR alternate-day | Bisglycinate (tolerance) or ferrous sulfate (rapid/cost) |
| Depleted iron stores without anaemia (NAID) | 25–80 mg/day | Morning, alternate-day preferred | Ferrous bisglycinate or liposomal iron |
| Pregnant women | 27–50 mg/day | With vitamin C | Ferrous bisglycinate or succinate |
| Athletes with depleted stores | 50–80 mg/day | Morning, alternate-day | Liposomal or bisglycinate |
Safety & Interactions
Iron binds levothyroxine in the gut, preventing thyroid hormone absorption. This can cause sudden under-treatment of hypothyroidism — elevated TSH, fatigue, cold intolerance — that mimics the exact symptoms iron is supposed to fix. Almost never flagged by GPs or pharmacists. Separate by minimum 4–5 hours.
Iron chelates the antibiotic molecule, destroying its antimicrobial activity. This is a clinically significant antibiotic failure risk. Separate by 2–4 hours, or switch to liposomal/bisglycinate iron.
Same chelation mechanism as tetracyclines. Taking iron near these antibiotics can render them ineffective for a serious infection. Separate by 2–4 hours.
Calcium forms insoluble complexes with iron in the gut, dramatically reducing absorption. Separate by 2 hours.
Polyphenols and tannins bind free iron in the gut. Common cause of supplementation failure. Separate by 1–2 hours.
Iron reduces bisphosphonate absorption, undermining osteoporosis management. Separate by more than 2 hours.
Iron chelates levodopa, reducing drug efficacy. Separate by more than 2 hours.
These medications reduce gastric acid needed to convert dietary iron into absorbable form. Ferrous bisglycinate and liposomal iron are less affected — prefer these forms if on long-term acid suppression.
The Nuance
| Population | Why they benefit | Evidence |
|---|---|---|
| Premenopausal women with iron-deficiency anaemia | Highest risk group. Menstrual losses routinely exceed dietary intake. Fatigue resolution is near-universal with adequate dosing. | STRONG |
| People with depleted stores and normal blood count (NAID) | The most underdiagnosed group. Profound fatigue, cognitive fog, reduced endurance that a standard blood test won't detect. | STRONG |
| Vegetarians and vegans | Plant iron absorbs at 2-10% vs 15-35% for animal iron. Require 1.8x the daily intake of meat-eaters to meet the same need. | STRONG |
| Female endurance athletes | Running-induced red blood cell destruction (foot-strike haemolysis), sweat losses, and restricted calories combine to make iron deficiency the most common nutritional deficiency in this population. | MODERATE |
| Pregnant women | Foetal demand doubles maternal iron requirement. Standard of care at 27-50 mg elemental/day. | STRONG (clinical standard) |
| Post-bariatric surgery | Duodenal bypass impairs the primary iron absorption site. Often requires IV iron; oral supplementation needs chelated or liposomal forms. | MODERATE |
| Form | Monthly cost (UK) | Food alternative | Value verdict |
|---|---|---|---|
| Ferrous sulfate (e.g. 210 mg tablet = 65 mg elemental) | £2–4 | Red meat (~3 mg heme iron/100g) | Worth it for urgent anaemia in GI-tolerant patients |
| Ferrous bisglycinate (e.g. Gentle Iron 25 mg) | £8–15 | Organ meats: liver (~6–7 mg/100g) | Clinical sweet spot for most use cases |
| Liposomal iron | £15–25 | No food equivalent for liposomal delivery | Justified for IBD, CKD, or after bisglycinate failure |
| Ferrous succinate (sustained release) | £3–6 | — | Cost-effective for pregnancy at population scale |
Sources
Retrospective cohort of US veterans with IDA: daily vs alternate-day vs multiple daily doses of oral iron — comparable final haemoglobin outcomes; multiple daily doses achieved faster initial rise.
Premenopausal women with IDA: ferrous sulfate 160 mg elemental/day × 8 weeks — fatigue ↓ (p<0.001), muscle endurance ↑ (p<0.001), haemoglobin ↑ 17.62%, VO2max not statistically significant.
Daily vs alternate-day oral iron: comparable haemoglobin efficacy; fractional absorption 21.8% vs 16.3% in favour of alternate-day (p=0.0013); better GI tolerance alternate-day.
Pregnant women with iron-deficiency anaemia: ferrous succinate 96.0% effective rate; ICER $3.23 per 1% efficacy gain — most cost-effective form in pregnancy.
Non-dialysis-dependent CKD with IDA: ferric citrate — haemoglobin ↑ 0.62 g/dL vs placebo (p<0.0001); serum phosphorus ↓ from 4.23 to 3.72 mg/dL.
Liposomal iron vs ferrous bisglycinate: haemoglobin response 1.8–2.4 g/dL vs 1.2–1.8 g/dL (p<0.01); GI side effects 5–15% vs 40–60% (p<0.001) in favour of liposomal.
RDA, upper limit, drug interaction data, population-specific requirements.
Upper intake level 40 mg/day for adults; population reference intakes.
How strong is the evidence for the claims in this review? Higher = more confidence the claims are supported. This does not measure how large the effect is or how important it is compared with other levers.
Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.
Evidence-scored dosing, timing, forms, and who should skip it. One page, no fluff.
Get the protocolConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.